Pancreatic cancer is one of the most difficult to treat due to its extreme resistance to treatment and few early symptoms. Currently, Eli Lilly’s (NYSE – LLY) Gemzar® is the only FDA-approved single agent that has demonstrated improvement in patient symptoms and overall survival (OS) in patients.
Market Data 
Markets 
AI
